 | Up a level |
2022
Rech, J., Kleyer, A., Ostergaard, M., Hagen, M., Valor, L., Tascilar, K., Kronke, G., Schonau, V., Kleinert, S., Baraliakos, X., Braun, J., Fleck, M., Rubbert-Roth, A., Behrens, F., Feuchtenberger, M., Zaenker, M., Kofler, D. M., Voll, R., Glaser, C., Hueber, A., Feist, E., Burmester, G. R., Karberg, K., Strunk, J., Canete, J. D. D., Senolt, L., Naredo, E. and Schett, G. (2022). ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS. Ann. Rheum. Dis., 81. S. 526 - 528. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
2019
Doerner, T., Schulze-Koops, H., Burmester, G. -R., Iking-Konert, C., Schmalzing, M., Engel, A., Kaestner, P., Kellner, H., Kurthen, R., Krueger, K., Rubbert-Roth, A., Schwenke, H., Peters, M. A. and Tony, H. -P. (2019). Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI). Clin. Exp. Rheumatol., 37 (6). S. 937 - 946. PISA: CLINICAL & EXPER RHEUMATOLOGY. ISSN 1593-098X
Gonzalez-Alvaro, Isidoro, Castrejon, Isabel, Carmona, Loreto, Dougados, M., Huizinga, T., Abu Shakra, M., Alberts, A., Alperi Lopez, M., Amital, H., Aringer, M., Aslanidis, S., Berenbaum, F., Bijlsma, H., Blanco Garcia, F. J., Bliddal, H., Borofsky, M., Brocq, O., Buldakov, S., Cantini, F., Carreno Perez, L., Chahade, W., Ciconelli, R., Codreanu, C., Dahlqvist, S. R., Damjanov, N., Diamantopoulos, A., Dimdina, L., Dimic, A., Dorokhov, A., Dubikov, A., Fadienko, G., Fano, N., Ferreira, G., Gabrielli, A., Gaffney, K., Gaudin, P., Gerlag, D. M., Gerli, R., Goncalves, C. R., Hansen, M. S., Hanvivadhanakul, P., Hoili, C., Hou, A., Hunter, J., Ilic, T., Ionescu, R., Kaine, J., Kakurina, N., Kamalova, R., Kelly, T., Knyazeva, L., Krumina, L., Kurthen, R., Lagrone, R. P., Lapadula, G., Lavrentjevs, V, Lawson, J. G., Lazic, Z., Lejnieks, A., Levy, Y., Lexberg, A., Mader, R., Mariette, X., Markovits, D., Mola, Martin E., Maugars, Y., Guarch, Maymo J., Mazurov, V., I, Mikkelsen, K., Vergles, Morovic J., Nabizadeh, S., Nanagara, R., Nasonov, E. L., Sarabia, Navarro F., Neumann, T., Novak, S., Olech, E., Oza, M., Paran, D., Parsik, E., Pegram, S., Suarez, Pombo M., Popova, T., Puechal, X., Raja, N., Ridley, D., Rosner, I, Rubbert-Roth, A., Rudin, A., Saraux, A., Saulite-Kandevica, D., Settas, L., Sfikakis, P., Sheeran, T., Sizikov, A., Stamenkovic, D., Stefanovic, D., Stolow, J. B., Tan, A. L., Tebib, J., Tishler, M., Tony, H. P., Troum, O. M., Uaratanawong, S., Ucar Angulo, E., Valenzuela, G., van der Laken, K., Van Laar, J., van Riel, P. L. C. M., Vasilopoulos, D., Veldi, T., Vinogradova, I, Vosse, D., Wassenberg, S., Weidmann, C., Weitz, M., Wollenhaupt, J., Xavier, R., Yakupova, S., Zagar, I, Zavgorodnaja, T., Zemerova, E., Zisman, D., Zonova, E., Camona, Loreto, Abasolo Alcazar, L., Alegre de Miguel, C., Andreu Sanchez, J. L., Aragon Diez, A., Balsa Criado, A., Batlle Gualda, E., Belmonte Serrano, M. A., Beltran Audera, J., Beltran Fabregat, J., Bonilla Hernan, G., Caro Fernandez, N., Casado, E., Cebrian Mendez, L., Corteguera Coro, M., Cuadra Diaz, J. L., Cuesta, E., Fiter Areste, J., Freire Gonzalez, M., Galindo Izquierdo, M., Garcia Meijide, J. A., Garcia Gomez, M. C., Gimenez Ubeda, E., Gomez Centeno, E., Gomez Vaquero, C., Gonzalez Fernandez, M. J., Gonzalez Gomez, M. L., Gonzalez Hernandez, T., Gonzalez-Alvaro, I, Gonzalez-Montagut Gomez, C., Grandal Delgado, Y., Gratacos Masmitja, J., Hernandez del Rio, A., Instxaurbe, A. R., Irigoyen Oyarzabal, M., V, Jimenez Palop, M., Juan Mas, A., Judez Navarro, E., Larrosa Padro, M., Lopez Longo, F. J., Loza Santamaria, E., Maese Manzano, J., Manero Ruiz, F. J., Mateo Bernardo, I, Mayordomo Gonzalez, L., Mazzucheli, R., Medrano San Idelfonso, M., Naranjo Hernandez, A., Pecondon Espanol, A., Peiro Callizo, E., Quiros Donate, J., Ramos Lopez, P., Rivera Redondo, J., Rodriguez Gomez, M., Rodriguez Lopez, M., Rosello Pardo, R., Sampedro Alvarez, J., Sanmarti Sala, R., Rey Rey, Santos J., Tena Marsa, X., Tenorio Martin, M., Torres Martin, M. C., Urena Garnica, I, Valdazo de Diego, J. P., Valls, M., Villaverde Garcia, V., Zarco Montejo, P., Zubieta Tabernero, J., Balsa, Alejandro, Sanmarti, Raimon, Cabezas, J. A., Cantalejo, M., Chamizo, E., Ciruelo, E., Corrales, A., Cruz, A., Diaz, C., Fiter, J., Freire, M. M., Galindo, M., Garcia de Vicuna, M. R., Gelman, S. M., Gonzalez Crespo, R., Gonzalez Fernandez, C., Gonzalez Fernandez, M. J., Gonzalez Hernandez, T., Gracia, A., Granados, J., Guzman, M. A., Irigoyen, M., V, Juan, A., Juanola, X., Laiz, A., Manero, F. J., Martinez, A., Martinez, F., Mata, C., Maymo, J., Navarro, F. J., Peiro, E., Perez, F., Perez, G., Perez, M., Pujol, M., Quiros, J., Ribas, B., Riera, M., Rivera, J., Rodriguez, J. M., Rodriguez Gomez, M., Rosello, R., Tenorio, M. and Toyos, F. J. (2019). The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity. PLoS One, 14 (4). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203
2017
Koehm, M., Rossmanith, T., Dauth, S., Alten, R., Aringer, M., Backhaus, M., Burmester, G., Feist, E., Kellner, H., Krueger, K., Mueller-Ladner, U., Rubbert-Roth, A., Tony, H-P., Wassenberg, S., Burkhardt, H. and Behrens, F. (2017). IMPACT OF RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE AND RITUXIMAB RETREATMENT WITH TWO DIFFERENT DOSAGES ON PATIENT-REPORTED OUTCOMES: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY). Ann. Rheum. Dis., 76. S. 565 - 566. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Kvien, T. K., van Riel, P., Rubbert-Roth, A., Blanco, R., Liu-Leage, S. S., Larsson, E., Lund, H., Lopez-Romero, P., Zaremba-Pechmann, L. and Emery, P. (2017). BARICITINIB VERSUS ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: ANALYSIS OF PATIENTS ACHIEVING A MODERATE EULAR RESPONSE AT WEEK 4. Ann. Rheum. Dis., 76. S. 794 - 796. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Rubbert-Roth, A., Bittenbring, J. T. and Assmann, G. (2017). Lymphoma in rheumatic diseases. Z. Rheumatol., 76. S. 46 - 57. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
2016
Behrens, F., Rossmanith, T., Kohm, M., Alten, R., Aringer, M., Backhaus, M., Baerwald, C., Burmester, G., Feist, E., Kellner, H., Krger, K., Muller-Ladner, U., Rubbert-Roth, A., Tony, H. -P., Wassenberg, S. and Burkhardt, H. (2016). RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY). Ann. Rheum. Dis., 75. S. 502 - 503. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Henkemeier, U., Alten, R., Bannert, B., Baraliakos, X., Behrens, F., Heldmann, F., Kiltz, U., Koehm, M., Koenig, R., Leipe, J., Mueller-Ladner, U., Rech, J., Riechers, E., Rubbert-Roth, A., Schmidt, R. E., Schulze-Koops, H., Specker, C., Tausche, A. -K, Wassenberg, S., Witt, M., Witte, T., Zernicke, J. and Burkhardt, H. (2016). Do we still need clinical studies in rheumatology? Z. Rheumatol., 75 (1). S. 4 - 11. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
Rubbert-Roth, A., Zander, T., Kneitz, C., Baerwald, C., Wirtz, H. and Witt, C. (2016). Lung cancer and rheumatoid arthritis. An interdisciplinary challenge. Z. Rheumatol., 75 (1). S. 47 - 54. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
2015
Albrecht, K., Englbrecht, M., Baerwald, C., Feist, E., Fleck, M., Gromnica-Ihle, E., Koehler, L., Koetter, I., Kneitz, C., Krueger, K., Kuipers, J., Nuesslein, H., Rubbert-Roth, A., Wollenhaupt, J., Schneider, M., Manger, B., Mueller-Ladner, U. and Tarner, I. H. (2015). National and Multinational Evidence-based Recommendations for Medical Pain Management in Inflammatory Joint Disease: Systematic Literature Research and Expert Opinion in the 3e Initiative. Aktuelle Rheumatol., 40 (1). S. 67 - 77. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-9940
Rubbert-Roth, A. (2015). Switching within the active ingredient group or changing the mechanism of action. Data situation by failure of the first line biologic. Z. Rheumatol., 74 (5). S. 406 - 414. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
2014
Alexander, T., Sarfert, R., Klotsche, J., Rubbert-Roth, A., Lorenz, H. -M., Rech, J., Hoyer, B., Cheng, Q., Waka, A., Taddeo, A., Kuehl, A. A., Schett, G., Burmester, G. -R., Radbruch, A., Hiepe, F. and Voll, R. E. (2014). THE PROTEASOME INHIBITOR BORTEZOMIB AMELIORATES REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A PROSPECTIVE MULTI-CENTRE OBSERVATIONAL STUDY. Ann. Rheum. Dis., 73. S. 530 - 531. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Burmester, G., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M., Roane, G., Ludivico, C., Mysler, E., Nash, P., Wells, C., Bennett, M. and Vranic, I (2014). THE EFFICACY AND SAFETY OF TOCILIZUMAB SUBCUTANEOUS VERSUS TOCILIZUMAB INTRAVENOUS, IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RA AT 49 WEEKS (SUMMACTA) (ENCORE). Intern. Med. J., 44. S. 25 - 27. HOBOKEN: WILEY-BLACKWELL. ISSN 1445-5994
Burmester, G., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M. J., Roane, G., Ludivico, C., Mysler, E., Bennett, M. J., Rowell, L. and Bao, M. (2014). THE EFFICACY AND SAFETY OF SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RA AT WEEK 97 (SUMMACTA). Ann. Rheum. Dis., 73. S. 499 - 501. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Gause, A. M. and Rubbert-Roth, A. (2014). Recommendations on the use of rituximab for ANCA-associated vasculitis. Z. Rheumatol., 73 (3). S. 287 - 290. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
Genovese, M., Sebba, A., Youssef, P., Rischmueller, M., Jones, G., Rubbert-Roth, A., Scali, J., Alten, R., Kremer, J., Pitts, L., Rowell, L. and Van Vollenhoven, R. (2014). LONG-TERM SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING A MEAN TREATMENT DURATION OF 3.9 YEARS (ENCORE). Intern. Med. J., 44. S. 25 - 26. HOBOKEN: WILEY-BLACKWELL. ISSN 1445-5994
Rubbert-Roth, A., Burmester, G. R., Doerner, T. and Gause, A. (2014). Recommendations for use of rituximab in patients with rheumatoid arthritis. Z. Rheumatol., 73 (2). S. 165 - 174. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
Tarner, I. H., Albrecht, K., Fleck, M., Gromnica-Ihle, E., Keysser, G., Koehler, L., Koetter, I., Krueger, K., Kuipers, J., Nuesslein, H., Rubbert-Roth, A., Wollenhaupt, J., Schneider, M., Manger, B. and Mueller-Ladner, U. (2014). Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative. Z. Rheumatol., 73 (4). S. 363 - 374. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
2011
Kalden, J., Burkhardt, H., Buss, B., Donhauser-Gruber, U., Erstling, U., Gromnica-Ihle, E., Karberg, K., Karger, T., Kneitz, Ch., Krause, A., Krueger, K., Lorenz, H-M., Mueller-Ladner, U., Rubbert-Roth, A., Steffens-Korbanka, P., Tony, H. -P., Wendler, J., Wollenhaupt, J. and Burmester, G. (2011). Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis. Z. Rheumatol., 70 (8). S. 641 - 650. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250